Long-chain omega-3 fatty acids improve brain function and structure in older adults

Cerebral Cortex

Volumn 24, Issue 11, 2014, Pages 3059-3068

  Witte, A Veronica ^a   Kerti, Lucia ^a   Hermannstädter, Henrike M ^a   Fiebach, Jochen B ^a   Schreiber, Stephan J ^a   Schuchardt, Jan Philipp ^b   Hahn, Andreas ^b   Flöel, Agnes ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

cognitive aging; diffusion tensor imaging; executive functions; intima media thickness; voxel based morphometry

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FISH OIL; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; CHOLESTEROL; LIPOPROTEIN;

ADULT; AGED; AGING; ARTERIAL WALL THICKNESS; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; LEFT HEMISPHERE; LIMBIC CORTEX; MALE; NEUROIMAGING; NORMAL HUMAN; PARIETAL CORTEX; RANDOMIZED CONTROLLED TRIAL; TEMPORAL CORTEX; WHITE MATTER; ANALYSIS OF VARIANCE; ANATOMY AND HISTOLOGY; ANTHROPOMETRY; BLOOD; BRAIN; DIET RESTRICTION; DRUG EFFECTS; IMAGE PROCESSING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE;

AGED; AGING; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BRAIN; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; COGNITION; DOUBLE-BLIND METHOD; FASTING; FATTY ACIDS, OMEGA-3; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIPOPROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; WHITE MATTER;

EID: 84910675089     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bht163     Document Type: Article

References (53)

1. Agrawal R, Gomez-Pinilla F 2012. "Metabolic syndrome' in the brain: Deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol. 590:2485-2499.
2. Alexander AL, Lee JE, Lazar M, Field AS. 2007. Diffusion tensor imaging of the brain. Neurotherapeutics. 4:316-329.
3. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A. 2007. Dietary patterns and risk of dementia: The Three-City cohort study. Neurology. 69:1921-1930.
4. Cansev M, Wurtman RJ. 2007. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience. 148:421-431.
5. Chiu C-C, Su K-P, Cheng T-C, Liu H-C, Chang C-J, Dewey ME, Stewart R, Huang S-Y. 2008. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 32:1538-1544.
6. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB, Muldoon MF. 2007. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett. 421:209-212.
7. Dickerson BC, Eichenbaum H. 2010. The episodic memory system: Neurocircuitry and disorders. Neuropsychopharmacology. 35:86-104.
8. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, James S, Voets N, Watkins K, Matthews PM et al. 2007. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain. 130:2375-2386.
9. Draganski B, Gaser C, Busch V, Schuierer G, Bogdahn U, May A. 2004. Neuroplasticity: Changes in grey matter induced by training. Nature. 427:311-312.
10. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112:257-269.
11. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM et al. 2011. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA. 108:3017-3022.
12. Fletcher PC, Henson RN. 2001. Frontal lobes and human memory: Insights from functional neuroimaging. Brain. 124:849-881.
13. Floel A, Witte AV, Lohmann H, Wersching H, Ringelstein EB, Berger K, Knecht S. 2008. Lifestyle and memory in the elderly. Neuroepidemiology. 31:39-47.
14. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
15. Fotuhi M, Mohassel P, Yaffe K. 2009. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: A complex association. Nat Clin Pract Neurol. 5:140-152.
16. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund L-O, Palmblad J. 2006. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: A randomized double-blind trial. Arch Neurol. 63:1402-1408.
17. Frey I, Berg A, Grathwohl D, Keul J. 1999. Freiburg questionnaire of physical activity-development, evaluation and application. Soz Praventivmed. 44:55-64.
18. Gomez-Pinilla F. 2008. Brain foods: The effects of nutrients on brain function. Nat Rev Neurosci. 9:568-578.
19. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 14:21-36.
20. Gu Y, Schupf N, Cosentino SA, Luchsinger JA, Scarmeas N. 2012. Nutrient intake and plasma beta-Amyloid. Neurology. 78:1832-1840.
21. Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M. 2012. The effects of long-Term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: A systematic review and meta-Analysis. J Alzheimers Dis. 28:191-209.
22. Jernigan TL, Archibald SL, Fennema-Notestine C, Gamst AC, Stout JC, Bonner J, Hesselink JR. 2001. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol Aging. 22:581-594.
23. Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ. 2004. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. 62:275-280.
24. Kawakita E, Hashimoto M, Shido O. 2006. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience. 139:991-997.
25. Klingberg T, Hedehus M, Temple E, Salz T, Gabrieli JD, Moseley ME, Poldrack RA. 2000. Microstructure of temporo-parietal white matter as a basis for reading ability: Evidence from diffusion tensor magnetic resonance imaging. Neuron. 25:493-500.
26. Krohne H, Egloff B, Kohlmann C, Tausch A. 1996. Untersuchungen mit einer deutschen Version der "Positive and Negative Affective Schedule" (PANAS). Diagnostica. 42:139-156.
27. Kuhner C, Burger C, Keller F, Hautzinger M. 2007. Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples. Nervenarzt. 78:651-656.
28. Laux L, Glanzmann P, Schaffner P, Spielberger C. 1981. Das State-Trait-Angst Inventar. Theoretische Grundlagen und Handanweisung. Weinheim: Beltz Test GmbH.
29. Lezak MD. 2004. Neuropsychological assessment. New York, Oxford: Oxford University Press.
30. Lowin A, Knapp M, McCrone P. 2001. Alzheimer's disease in the UK: Comparative evidence on cost of illness and volume of health services research funding. Int J Geriatr Psychiatry. 16:1143-1148.
31. Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. 1991. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J Neurochem. 56:518-524.
32. Morris JC. 2005. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics. (Suppl):9-14.
33. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 24:10099-10102.
34. Plassman BL, Langa KM, McCammon RJ, Fisher GG, Potter GG, Burke JR, Steffens DC, Foster NL, Giordani B, Unverzagt FW et al. 2011. Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol. 70:418-426.
35. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M et al. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA. 304:1903-1911.
36. Raz N, Rodrigue KM, Kennedy KM, Head D, Gunning-Dixon F, Acker JD. 2003. Differential aging of the human striatum: Longitudinal evidence. Am J Neuroradiol. 24:1849-1856.
37. Reddy R, Fleet-Michaliszyn S, Condray R, Yao JK, Keshavan MS, Reddy R. 2011. Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study. Prostaglandins Leukot Essent Fatty Acids. 84:79-83.
38. Rybakowski JK, Borkowska A, Skibinska M, Hauser J. 2006. Illnessspecific association of val66met BDNF polymorphism with performance onWisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry. 11:122-124.
39. Salvati S, Natali F, Attorri L, Di Benedetto R, Leonardi F, Di Biase A, Ferri F, Fortuna S, Lorenzini P, Sanchez M et al. 2008. Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res. 86:776-784.
40. Sekikawa A, Kadowaki T, El-Saed A, Okamura T, Sutton-Tyrrell K, Nakamura Y, Evans RW, Mitsunami K, Edmundowicz D, Nishio Y et al. 2011. Differential association of docosahexaenoic and eicosapentaenoic acids with carotid intima-media thickness. Stroke. 42:2538-2543.
41. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM et al. 2006. Tract-based spatial statistics: Voxelwise analysis of multisubject diffusion data. Neuroimage. 31:1487-1505.
42. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. 2002. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage. 17:1429-1436.
43. Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, Pikula A, Decarli C, Wolf PA, Vasan RS et al. 2012. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 78:658-664.
44. Thomas C, Baker CI. 2013. Teaching an adult brain new tricks: A critical review of evidence for training-dependent structural plasticity in humans. NeuroImage 73:225-236.
45. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M et al. 2007. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 23:75-80.
46. Turken AU, Dronkers NF. 2011. The neural architecture of the language comprehension network: Converging evidence from lesion and connectivity analyses. Front Syst Neurosci. 5:1.
47. Turner GR, Spreng RN. 2012. Executive functions and neurocognitive aging: Dissociable patterns of brain activity. Neurobiol Aging. 33:826. ; e1-13.
48. Van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP. 2008. Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial. Neurology. 71:430-438.
49. Von Schacky C, Harris WS. 2007. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 73:310-315.
50. Walhovd KB, Fjell AM, Reinvang I, Lundervold A, Dale AM, Eilertsen DE, Quinn BT, Salat D, Makris N, Fischl B. 2005. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging. 26:1261-1270; discussion 1275-1268.
51. Wu A, Ying Z, Gomez-Pinilla F. 2004. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma. 21:1457-1467.
52. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M. 2010. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 6:456-464.
53. Zhao WQ, Chen H, Quon MJ, Alkon DL. 2004. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol. 490:71-81.